Ingenium publishes biological characterization of first mouse model for kidney stones

September 03, 2003

Ingenium Pharmaceuticals AG announced today the publication in the journal Human Molecular Genetics of the first mouse model for cystinuria type I, a disease commonly known as kidney stones. The mouse mimics the clinical manifestations of the human disease and represents a novel model for researching therapeutic approaches.

"The Human Molecular Genetics publication describes a prime example of an INGENOtypes® model: biologically well-characterized and an improvement over current models because it is the result of single base pair substitutions in the gene, which produces a phenotype closely representing a human disease state," stated Michael C. Nehls, M.D., Ph.D., Chief Executive Officer at Ingenium. "The publication underscores the value of our models for biomedical research in the areas of disease analysis and drug compound and therapeutic hypotheses testing."

As described in the publication, the mouse model was identified as part of Ingenium's Deductive GenomicsTM research, which involves a screen for medically relevant phenotypes in a third generation of mice treated with ENU, a chemical process that generates point mutations in genes. This specific model was located due to raised levels of urea in the blood, a hallmark of impaired renal function.

Further research located multiple similarities with the human disease cystinuria type I including the presence of relatively large calculi or "stones" in the urinary tract of the animal. Ingenium researchers located the mutation responsible for the disease state in the Slc3a1 gene. Mutations in the human Slc3a1 gene have long been associated with cystinuria, demonstrating a direct link and further validation of the mouse as a model for cystinuria type I disease research.

"The goal of our research is to better understand the molecular pathway involved with cystinuria type I and this model is a welcome addition because it is the first model that so closely mimics the human disease state," stated Dr. Thomas Knoll, noted specialist in urology research at the University Hospital Mannheim.

The paper, entitled "A Mouse Model for Cystinuria Type I", was published September 1, 2003 in Human Molecular Genetics, Vol. 12. Number 17, 2109-2120. Authors on the paper include T. Peters, C. Thaete, S. Wolf, A. Popp, R. Sedlmeier, J. Grosse, M.C. Nehls, A. Russ and V. Schlueter, all currently or formerly of Ingenium.

Ingenium Pharmaceuticals

Related Kidney Stones Articles from Brightsurf:

Otters juggle stones when hungry, research shows
Hunger is likely to be the main driver of stone juggling in otters, new research has shown.

Volcano F is the origin of the floating stones
Since August a large accumulation of pumice has been drifting in the Southwest Pacific towards Australia.

New treatment could ease the passage of kidney stones
Researchers at MIT and Massachusetts General Hospital have devised a potential new treatment that could make passing kidney stones faster and less painful, and eliminate surgery.

Physics of windshield-cracking raindrops could demolish kidney stones
A plane has to be going pretty fast for a mere raindrop to crack its windshield, but it can happen.

System for studying diseases like gout and kidney stones finds new drug targets
A new fruit fly model that mimics diseases associated with high uric acid levels, such as gout and kidney stones, has revealed new targets for developing treatments for these diseases.

Mayo Clinic researchers develop prediction tool for kidney stones
Kidney stones are a common and painful condition, with many sufferers experiencing recurrent episodes.

Molecular details of protein reveal glimpse into how kidney stones form
Using the 2017 Nobel Prize-winning technique of cryo-electron microscopy to capture a high-resolution image of an ion channel protein, called TRPV5, that removes calcium from urine, researchers have found fresh clues as to how kidney stones form.

Study: Kidney stones have distinct geological histories
A geologist, a microscopist and a doctor walk into a lab and, with their colleagues, make a discovery that overturns centuries of thought about the nature and composition of kidney stones.

Oral antibiotics may raise risk of kidney stones
Pediatric researchers have found that children and adults treated with some oral antibiotics have a significantly higher risk of developing kidney stones.

Researchers discover experimental obesity drug prevents development of kidney stones
Copenhagen: Scientists have found that a drug connected with fat regulation prevents the formation of kidney stones in mice.

Read More: Kidney Stones News and Kidney Stones Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to